WebEndoscopic biopsy specimens from primary lesions were collected in 445 of 704 randomized patients in JCOG9912. We measured the mRNA expression of excision repair cross-complementing group 1 (ERCC1), thymidylate synthase, dihydropyrimidine dehydrogenase, and five other genes, then, categorized them into low and high groups relative to the … Web1 feb 2016 · PDF Background The standard chemotherapy regimen for gastric cancer has been established by several phase III trials. However, few studies have... Find, read and cite all the research you need ...
Excision repair cross-complementary group for chemotherapy …
Web1 gen 2016 · JCOG9912 did not prespecify subsequent treatment, including second-line or third-line chemotherapy regimens. As a result, physician management choices, including those related to subsequent treatment, might have contributed significantly to the heterogeneity among participating hospitals, including the large gap in estimated OS … WebTable II . The JCOG9912 and JCOG0106 trials were conducted during the period of our analysis and 30% of the patients at TCC were also enrolled in those trials. The median survival time was 11.7 months and the median follow-up period of the survivors was 17.5 months (range, 1.4-43 months). Complications. As determined by our diagnostic criteria, the bowling terminology and definitions
Determination of prognostic factors in Japanese patients with
WebBackground: Two randomized phase III trials of first-line chemotherapy for advanced gastric cancer (JCOG9205 and JCOG9912) conducted by the Japan Clinical Oncology Group … WebImpact of excision repair cross-complementing gene 1 (ERCC1) on the outcomes of patients with advanced gastric cancer: correlative study in Japan Clinical Oncology Group Trial … Web目的 探讨基层医院腹腔镜辅助阴式子宫全切除术的治疗效果.方法 回顾性分析2013年6月~2015年12月在我院行腹腔镜辅助阴式全子宫切除术患者47例的临床资料.结果 46例患者手术成功,成功率97.87%;1例因肌瘤较大中转开腹切除术.本组腹腔镜辅助阴式子宫切除手术时间平均104(81~195)min,出血量平均12 gumtree cars edinburgh gumtree